Hyperpolarized [2–13C]pyruvate MR molecular imaging with whole brain coverage
Year: 2023
Type: article
Abstract: Hyperpolarized (HP) 13C Magnetic Resonance Imaging (MRI) was applied for the first time to image and quantify the uptake and metabolism of [2-13C]pyruvate in the human brain to provide new metabolic information on cerebral energy metabolism. HP [2-13C]pyruvate was injected intravenously and imaged in 5 healthy human volunteer exams with whole brain coverage in a 1-minute acquisition using a specialized spectral-spatial multi-slice echoplanar imaging (EPI) pulse sequence to acquire 13C-labeled volumetric and dynamic images of [2-13C]pyruvate and downstream metabolites [5-13C]glutamate and [2-13C]lactate. Metabolic ratios and apparent conversion rates of pyruvate-to-lactate (kPL) and pyruvate-to-glutamate (kPG) were quantified to investigate simultaneously glycolytic and oxidative metabolism in a single injection.
Source: NeuroImage
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,450
Awards: Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods, G5800834670, Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma, Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma, Hyperpolarized MRI Technology Resource Center, Imaging and Genomic Signatures of Brain Tumor Heterogeneity and Evolution to Optimize Patient Management
OpenAlex ID: W4386157381
